LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.
Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.
Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.
Each year on 4 February, World Cancer Day empowers all of us across the world to show support, raise our collective voice, take personal action and press our governments to do more. Two weeks ago, Lung Cancer Europe joined the the 3-year ‘I Am and I Will’ campaign initiated by Union for International Cancer Control. ‘I Am and I Will’ is an […]
Lung Cancer Europe (LuCE) marked the World Cancer Day by launching the European Call to Action Campaign. The call highlights the existing disparities in access the treatment and healthcare services for lung cancer patients and the actions to tackle them. Stefania Vallone, LuCE president, spoke to Health Europe Quaterly about the disparities and barriers that remain in access to innovative […]
Lung Cancer Europe was present at the European Cancer Forum held in Brussels. Brussels, 4 December 2018 MSD, in collaboration with Lung Cancer Europe and the European Cancer Patient Coalition, held the European Cancer Forum in Brussels to discuss around topics such as how to improve outcomes for people living with lung cancer, how to enable access to innovation within […]
Welcome to the 3rd edition of the LuCE Report. This report is an annual initiative led by lung cancer patient organisations, with the purpose of raising awareness about the biggest challenges that patients across Europe face. This 3rd report focusses on clinical trials and welcomes the progress made in lung cancer treatment in recent years. However, it also seeks to […]
